[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=64cea47b63227756a4b8d35a71a1453c4333118990de110d136c64020e763737",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747413840,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134538639,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=64cea47b63227756a4b8d35a71a1453c4333118990de110d136c64020e763737"
    }
  },
  {
    "ts": null,
    "headline": "75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition",
    "summary": "Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world’s largest pre-college STEM competition in Columbus, Ohio TARRYTOWN, N.Y. and WASHINGTON, May 16, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, won the $100,000 George D. Yancopoulos Innovator Award at the 75th Regenero",
    "url": "https://finnhub.io/api/news?id=278c455d5ad5dc59c8b0132efe6cd964015174774b625c71841115c37f1f1da4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747409040,
      "headline": "75th Annual Regeneron International Science and Engineering Fair Awards Teen Scientists from Around the World More Than $9 Million in 2025 Competition",
      "id": 134498929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world’s largest pre-college STEM competition in Columbus, Ohio TARRYTOWN, N.Y. and WASHINGTON, May 16, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, won the $100,000 George D. Yancopoulos Innovator Award at the 75th Regenero",
      "url": "https://finnhub.io/api/news?id=278c455d5ad5dc59c8b0132efe6cd964015174774b625c71841115c37f1f1da4"
    }
  },
  {
    "ts": null,
    "headline": "Replimune Group: Analysts Are More Optimistic Than The Market",
    "summary": "Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced melanoma. Read the latest REPL stock analysis here.",
    "url": "https://finnhub.io/api/news?id=bb77fd23fe6024b930fdae4bb9e7a6df8f78a2dbd277bd2fa5e0a398dacca4da",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747405350,
      "headline": "Replimune Group: Analysts Are More Optimistic Than The Market",
      "id": 134500847,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1473708731/image_1473708731.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced melanoma. Read the latest REPL stock analysis here.",
      "url": "https://finnhub.io/api/news?id=bb77fd23fe6024b930fdae4bb9e7a6df8f78a2dbd277bd2fa5e0a398dacca4da"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff",
    "summary": "A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.",
    "url": "https://finnhub.io/api/news?id=4c19503761ecdbad37a505fbd071ae5971062de1487beb3ed376e4d10e1e98a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747391760,
      "headline": "Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff",
      "id": 134498741,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "A federal jury found Amgen liable for violating antitrust and tort laws. Elsewhere, Allogene and Kyverna trimmed staff and the FDA scheduled an advisory meeting.",
      "url": "https://finnhub.io/api/news?id=4c19503761ecdbad37a505fbd071ae5971062de1487beb3ed376e4d10e1e98a9"
    }
  },
  {
    "ts": null,
    "headline": "1 Nasdaq 100 Stock with Exciting Potential and 2 to Think Twice About",
    "summary": "While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.",
    "url": "https://finnhub.io/api/news?id=11b5a85b69812c9535753eb0769f4e4692411ee5f11c1a79542b4b9a73882af2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747370089,
      "headline": "1 Nasdaq 100 Stock with Exciting Potential and 2 to Think Twice About",
      "id": 134498932,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "While the Nasdaq 100 (^NDX) is filled with cutting-edge technology and consumer companies, not all are on solid footing. Some are dealing with declining demand, high costs, or regulatory pressures that could limit future upside.",
      "url": "https://finnhub.io/api/news?id=11b5a85b69812c9535753eb0769f4e4692411ee5f11c1a79542b4b9a73882af2"
    }
  }
]